Moreover, PERK silencing inhibited glioma cell viability and tumor growth by blocking AKT phosphorylation and consequently disrupting HK2's mitochondria translocation and glycolysis under low glucose metabolism stress. The gene discussed is EIF2AK3; the disease is central nervous system cancer.